Clinical Data Management and Statistical Analysis process of gathering, scrubbing, and managing subject data in accordance with legal requirements. The main goal of Clinical Data Management and Statistical Analysis procedures is to deliver high-quality data by minimizing errors and missing data while collecting as much data as feasible for analysis. Clinical Data Management and Statistical Analysis is a crucial stage in clinical research that produces high-quality, trustworthy, and statistically sound data from clinical trials. This results in a significantly shorter period of time between drug development and launch. From the beginning to the end of a clinical trial, CDM team members are actively involved. They ought to have sufficient process knowledge to support upholding the CDM processes' high levels of quality.
Highlights from Clinical Data Management and Statistical Analysis Market Study
|Unit||Value (USD Million)|
The key Players profiled in the report are Parexel (United States), Quanticate (United Kingdom), Labcorp (United States), Iqvia (United States), Navitas Life Sciences (United States), Veranex (United States), MMS Holdings (United States), PRA Health Sciences (United States), Starlims (United States) and Vial Connect (United States). Additionally, other players that are part of this comprehensive study are Auriga Research Private Limited (India) and Medpace (United States).
Geographic Breakdown and Segment Analysis
The Global Clinical Data Management and Statistical Analysis market presents a comprehensive analysis of the Clinical Data Management and Statistical Analysis market and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Clinical Data Management and Statistical Analysis industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Clinical Data Management and Statistical Analysis market
Analyst at AMA have segmented the market study of Global Clinical Data Management and Statistical Analysis market by Type, Application and Region.
Influencing Trend:Rapid Uses of Artificial Intelligence in Clinical Data Management and Statistical Analysis, Innovation of Electronic Clinical Outcome Assessment and Demand of Cloud-Based Clinical Metadata Repositories in Clinical Data Management and Statistical Analysis
Market Growth Drivers:Increasing Demand Of Data Management In Medical And Healthcare Centers and Rising Demand In Maintaining Clinical Research And Clinical Trials
Challenges:Government Regulations Associated with Clinical Data Management and Statistical Analysis, Lack of Skilled Professionals for Clinical Data Management and Statistical Analysis and Delaying in Clinical Trials and Lack of Recognizing Trail Issues
Restraints:Privacy and Security Rule of Patient Associated with Clinical Data Management and Statistical Analysis
Opportunities:Growth in New Advanced Technologies and Data Science and Growing Medical and Healthcare Industry
On 24 June 2021, IQVIA introduced Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use. This produces a scalable repository, that helps meet regulatory requirements, for stakeholders to investigate operational and clinical data. It also drives faster predictive analytics using AI/ML, enabling smarter decisions across all parts of a clinical trial.
Regulatory Insights:CDM has guidelines and standards that must be followed. Since the pharmaceutical industry relies on the electronically captured data for the evaluation of medicines, there is a need to follow good practices in CDM and maintain standards in electronic data capture. These electronic records have to comply with a Code of Federal Regulations (CFR), 21 CFR Part 11. This regulation is applicable to records in electronic format that are created, modified, maintained, archived, retrieved, or transmitted. This demands the use of validated systems to ensure accuracy, reliability, and consistency of data with the use of secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions that create, modify, or delete electronic records.
The market for Clinical Data Management and Statistical Analysis is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as service innovation and using various marketing strategies to gain a higher market share.
Key Target AudienceClinical Data Management and Statistical Analysis Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others